Ezmedibot Selected for Ministry of Food and Drug Safety's Innovative Medical Device Technical Support Project
Ezmedibot, a subsidiary of WSI, has been selected for the “2026 Innovative Medical Device Full Lifecycle Technical Support” project, supervised by the Ministry of Food and Drug Safety, with its surgical assistant robot “U-BOT.”
According to Ezmedibot on May 20, this project was established to promote the development and rapid commercialization of innovative medical devices that have secured safety and efficacy. It provides customized technical support necessary for innovative medical device designation and regulatory approval, as well as step-by-step comprehensive consulting through the formation of dedicated teams for each company.
U-BOT is a robotic automation system used under a physician’s control for positioning, fixation, traction of the uterus, and manipulation of implants in procedures such as hysterectomy, myomectomy, and oophorectomy. It consists of a control unit and a drive-operating robotic arm.
With this selection, Ezmedibot will receive systematic and expert consulting throughout the regulatory approval and innovative medical device designation process. This is expected to further strengthen the foundation for domestic commercialization of U-BOT.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
An Ezmedibot representative stated, “This selection is an official recognition by a national institution of U-BOT’s technological capability and innovation,” and added, “We will accelerate domestic commercialization through full lifecycle technical support and actively pursue global market entry, including obtaining overseas regulatory approvals.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.